Study Of AG-013736 (Axitinib) In Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
To evaluate the clinically recommended dose of AG-013736 (Axitinib) in Japanese patients by
reviewing the safety of AG-013736 (Axitinib) following single and multiple dosing.